Foreign-invested pharmaceutical firms call for more tax exemptions for multinational clinical trials

Korea will have to seek to expand tax exemptions for multinational clinical trials as well as foreign corporate investment Korea is rapidly emerging as a global hub of clinical trials for multinational pharmaceutical companies thanks to its excellent infrastructure for clinical research, according to the Korean Research based Pharmaceutical Industry Association (KRPIA).

“These clinical trial...